BSD Medical Signs Distribution Agreement with Comed Medical Specialties for MicroThermX® Microwave Ablation Products

  BSD Medical Signs Distribution Agreement with Comed Medical Specialties for
  MicroThermX® Microwave Ablation Products

Business Wire

SALT LAKE CITY -- July 10, 2014

BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (,
a leading provider of medical systems that utilize heat therapy to treat
cancer, announced today that the Company has signed an agreement with Comed
Medical Specialties (Comed) for the sales and distribution of the MicroThermX
Microwave Ablation (MicroThermX) line of products.

Comed Medical Specialties is the number one specialty medical distributor in
the Western United States. Comed has a thirty-year history of selling
innovative medical devices to the interventional radiology market. Comed has
well-established, key relationships with department heads at interventional
radiology institutions throughout the West. Comed has 10 sales personnel
specializing in selling innovative surgical and interventional radiology

Based in Salt Lake City, Utah, Comed has the rights to market the MicroThermX
^ line of products in Arizona, California, Colorado, El Paso, Texas, Nevada,
New Mexico, and Utah. Comed’s sales team will work hand-in-hand with BSD sales
management and BSD’s direct sales representatives and clinical specialist in
the West to penetrate one of the largest target markets for MicroThermX
products in the United States.

“We are pleased to partner with a distributor of Comed’s caliber in
interventional radiology products, as this is another essential step in
presenting the advantages of the MicroThermX to opinion leaders throughout the
West,” said Brian Ferrand, BSD Vice President of Domestic Sales. “Comed has
long-established relationships with key interventional radiologists and
capital equipment purchasers, which will increase sales of our products in the
Western United States.”

“The chance to distribute BSD’s MicrothermX product line is exceptionally
attractive to Comed,” said Mike Mahoney, Principal with Comed. “Microwave
ablation technology is in a rapidly growing market sector for treating cancer
and Comed sees a tremendous opportunity to offer MicroThermX to its extensive
base of established customers.”

About the MicroThermX ^  Microwave Ablation System

The MicroThermX Microwave Ablation System is a compact, mobile,
state-of-the-art, proprietary system that includes a microwave generator,
single-patient-use disposable antennas, and a thermistor-based temperature
monitoring system. The innovative design of the MicroThermX ^ is the first of
its kind that allows delivery of higher power levels using a single generator.
The MicroThermX ^ utilizes innovative synchronous phased array technology that
was developed and patented by BSD to provide larger and more uniform zones of
ablation during a single procedure. The MicroThermX product line includes an
innovative, high-end disposable that is used in each ablation treatment, and
provides ongoing revenue streams for BSD. The soft tissue ablation world
market potential is estimated to exceed $2.3 billion. The U.S. Food and Drug
Administration (FDA) has granted the Company a 510(k) clearance to market the
MicroThermX for ablation of soft tissue. BSD has also received CE Marking for
the MicroThermX System, which allows BSD to market the MicroThermX ^ system in
Europe. CE marking is also recognized in many countries outside of the EU,
providing BSD the ability to market the MicroThermX ^ to a number of
international markets.

About BSD Medical Corporation

BSD Medical Corporation develops, manufactures, markets and services systems
to treat cancer and benign diseases using heat therapy, which is delivered
using focused radiofrequency (RF) and microwave energy. BSD’s product lines
include both hyperthermia and ablation treatment systems. BSD’s MicroThermX
microwave ablation system has been developed as a stand-alone therapy to
employ precision-guided microwave energy to ablate (destroy) soft tissue. The
Company has developed extensive intellectual property, multiple products in
the market and established distribution in the United States, Europe and Asia.
Certain of the Company’s products have received regulatory approvals and
clearances in the United States, Europe and China. For further information
visit BSD Medical's website

This press release may be deemed to contain forward-looking statements, which
are subject to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Readers are cautioned that these forward-looking
statements are only predictions and may differ materially from actual future
events or results due to a variety of factors, including, among other things,
the demand for the Company’s products, the ability of the Company to produce
the products to meet the demand, global economic conditions and uncertainties
in the geopolitical environment and other risk factors set forth in the
Company’s most recent reports on Form 10-K and Form 10-Q. Any forward-looking
statements in this release are based on limited information currently
available to the Company, which is subject to change, and the Company will not
necessarily update the information.


Financial Profiles
Tricia Ross, 310-622-8226
Press spacebar to pause and continue. Press esc to stop.